Large increase seen in mortality with ADRD as underlying, contributing cause of death in pandemic year 1<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, July 19, 2023 (HealthDay News) — In COVID-19 pandemic year 1, there was a large increase in mortality with Alzheimer disease and related dementias (ADRD) as an underlying or contributing cause of death, which was largely mitigated in year 2, according to a study published online July 17 in JAMA Neurology<\/em>.<\/p>\n Ruijia Chen, Sc.D., from the University of California in San Francisco, and colleagues compared pandemic-era excess deaths associated with ADRD between year 1 and year 2 of the COVID-19 pandemic in a time series analysis for U.S. decedents aged 65 years and older with ADRD as an underlying or contributing cause of death. A total of 2,334,101 death certificates were analyzed.<\/p>\n The researchers identified 94,688 pandemic-era excess deaths with ADRD in year 1 and 21,586 in year 2. For every age, sex, and racial and ethnic group evaluated, declines in ADRD-related deaths in year 2 were substantial. Among nursing home\/long-term care residents, pandemic-era ADRD-related excess deaths decreased from 34,259 in year 1 to 22,050 in year 2, but excess deaths at home remained high (34,487 and 28,804, respectively).<\/p>\n “Our findings underscore the urgent need to mitigate the pandemic’s impacts on community-dwelling older adults with ADRD,” the authors write.<\/p>\n One author disclosed ties to Johnson & Johnson and Swiss Re.<\/p>\n